Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Allium sativum oil, commonly known as garlic oil, is a botanical extract derived from the bulbs of *Allium sativum*. It contains various organosulfur compounds, such as allicin, diallyl sulfide, and diallyl disulfide, which contribute to its biological activities. In clinical dentistry, it is being investigated as a natural, cost-effective alternative to traditional medicaments like formocresol or mineral trioxide aggregate (MTA) for non-vital pulpotomy in primary teeth, due to its potent antibacterial properties against oral pathogens like *Streptococcus mutans* and *Lactobacillus acidophilus*. Additionally, preclinical research suggests it may have immunomodulatory and anti-inflammatory effects, potentially improving chronic inflammation in hyperlipidemic conditions by modulating T-cell activation and reducing proinflammatory cytokines like TNF-α and IFN-γ via the NF-κB pathway.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on allium sativum oil.